Back to News
Market Impact: 0.42
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
Source: cnbc.com
Healthcare & BiotechConsumer Demand & RetailCompany Fundamentals
Eli Lilly CEO Dave Ricks said 700,000 new seniors have begun GLP-1 therapies since Medicare started covering obesity drugs in July, with approximately 70% using Lilly medicines. The data signals substantial incremental demand from Medicare beneficiaries and supports Lilly's competitive position in the obesity-drug market.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.58
Ticker Sentiment
LLY0.72
More News
- We're booking big profits in 2 outperformers in Thursday's terrible market
- HALOZYME REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE
- Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- RIP the Cybertruck: Elon Musk says Tesla will wind down production of its most polarizing EV
- Tesla will stop making the Cybertruck in 2027